Eli Lilly Dealt Another Setback as Lung Cancer Drug Flunks Phase III Test Post author:Sam Post published:October 9, 2017 Post category:BioPharma October 10, 2017By Alex Keown, BioSpace.com Breaking… Source: BioSpace You Might Also Like Karolinska Development AB Release: Pharma Portfolio Company Announces FDA 510(K) Clearance For Marketing Of OSSDSIGN Cranial For Sale In The U.S.A. January 19, 2017 First Patient At Implanted In EndoStim's LESS GERD Clinical Trial For Gastroesophageal Reflux Disease (GERD) August 31, 2017 GlaxoSmithKline's Booming Pipeline Under CEO Emma Walmsley February 6, 2018
Karolinska Development AB Release: Pharma Portfolio Company Announces FDA 510(K) Clearance For Marketing Of OSSDSIGN Cranial For Sale In The U.S.A. January 19, 2017
First Patient At Implanted In EndoStim's LESS GERD Clinical Trial For Gastroesophageal Reflux Disease (GERD) August 31, 2017
